The Clorox Company (NYSE:CLX) Shares Bought by Stegent Equity Advisors Inc.

Stegent Equity Advisors Inc. lifted its stake in The Clorox Company (NYSE:CLX) by 19.2% in the fourth quarter, HoldingsChannel reports. The fund owned 2,531 shares of the company’s stock after purchasing an additional 408 shares during the quarter. Stegent Equity Advisors Inc.’s holdings in Clorox were worth $411,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. State Street Corp raised its holdings in shares of Clorox by 3.1% in the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp raised its holdings in shares of Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after purchasing an additional 37,967 shares in the last quarter. Finally, Van ECK Associates Corp raised its holdings in shares of Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 2.5 %

Clorox stock opened at $153.15 on Thursday. The firm has a market cap of $18.87 billion, a PE ratio of 41.84, a P/E/G ratio of 2.62 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm’s 50 day moving average price is $157.23 and its two-hundred day moving average price is $160.08. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the firm posted $2.16 EPS. On average, research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.19%. Clorox’s dividend payout ratio is presently 133.33%.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of research reports. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Barclays boosted their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Evercore ISI boosted their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.